Verruca Vulgaris
📧 Sign up to get email alerts when something new happens for Verruca Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. [Phase 2]
Phase 2 trial of intralesional cidofovir for recalcitrant warts in immunosuppressed pediatric patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-01-28Clinical Trial Update: The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) [Phase 1]
A Phase 1 trial evaluating the safety of topical PEP005 for the treatment of common warts has been withdrawn.